Vishal Mukund Sonje, Vaccine Manufacturing Lead, CEPI, talks about the challenges that arise in the manufacturing of vaccines ...

In this interview, SGD’s Najet Mebarki previews more than a half dozen products and services the company will showcase at the ...

Pharmaceutical Technology® spoke with Tara Dougal, Event Director for Pharma at Informa Markets about what attendees at CPHI ...

Pharmaceutical Technology® spoke with Tara Dougal, Event Director for Pharma at Informa Markets about what attendees at CPHI ...

US domestic manufacturing investment, R&D model shifts, new excipients, and digital traceability are redefining drug development and supply chains.

The new partnership will work to embed digital identification into labware, solving chain-of-identity challenges for ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Major pharmaceutical investments in the United States are expanding API, capsule, and packaging capacity, enhancing supply chain resilience and supporting domestic drug production.

At CPHI and AAPS, Ashland plans to detail the impacts of its advanced excipients: ultra-low nitrite materials curb ...

In episode 27, Christopher Hopkins, PhD; Omkar Kawalekar, PhD; Barnaby Pickering; and Jerry Rosenbaum, MD, go behind the ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

Biopharma data showed M&A strength, selective venture capital favoring Phase II, record obesity deals, and significant ...